Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Mikhaylov Vladimir was born on March 21, 1959 in Uglich, Yaroslavl province, Russia Professional experience: 1976- 1982- has finished the Ryazan medical institute named after I.P. Pavlov. 1982-1983- Emergency Hospital Ryazan medical interns surgical department 1983-1985 - Regional Hospital of Kozmodemyansk, Mari ASSR -surgical oncologist 1985-1989- Regional Cancer Hospital, Ryazan – surgical oncologist 1989-1987 - State Research Center of Laser Medicine, Moscow, Senior Research Fellow, Department of Surgery of the biliary tract and parenchymal organs, 1994 - is nominated as the conducting scientific employer, Department of Surgery of the esophagus and stomach. 1997 – 2000 - Head of Moscow Scientific-Practical Center of laser Medicine. 2000 – 2006 -General director of Scientific medical laser Center, Moscow. Since 2006 - private practices on family medicine in Moscow. 2013- Physician Contract with Eternity Medicine Institute, Dubai
We became used LLLT for the treatment of cancer diseases since 1988. The experimental studies were conducted in three areas: 1.Study the effect of different doses LLLT on the growth of experimental tumors. Implanted - Walker's carcinosarcoma n256 (from the U.S.A. bank)- (26 rats) and cancer of the mammary gland RMK-1 (75 rats). Spontaneous –mice with cancer of mammary glands type B -(188 animals), 2.Evaluation of the effectiveness of use LLLT in combination with various chemotherapeutic agents (vincristin,5-Fu,ciclophosphan) -Walker's (31 animals), , RMK-1 (63 animals). 3.The effect LLLT on the accumulation of hematoporphyrine derivatives -Walker's (188 animals). Clinical study: Breast cancer: Before surgery – 41 patients (II-III st.). In postoperative period- 38 patients (III-IV st.). Only LLLT- 57 patients (IV st.) Cancer of esophagus- (LLLT) + external radial therapy under the radical program - 20 patients, only LLLT-15 patients (T3NoMx). Only LLLT- 63 patients (IV st.). Cancer of stomach: LLLT before surgery -112 patients (IV st.). Only LLLT- 173 patients (IV st.). Cancer of colon: LLLT before surgery -61 patients ( IV st).). Only LLLT- 24 patients (IV st.). Cancer of rectum: LLLT before surgery -44 patients (IV st) Only LLLT- 17 patients (IV st.). Patients with other localizations of tumor (IV st.) – 139 patients.